KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Assets Average (2016 - 2025)

Historic Assets Average for Vertex Pharmaceuticals (VRTX) over the last 16 years, with Q3 2025 value amounting to $24.4 billion.

  • Vertex Pharmaceuticals' Assets Average rose 1540.32% to $24.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $24.4 billion, marking a year-over-year increase of 1540.32%. This contributed to the annual value of $22.6 billion for FY2024, which is 1071.96% up from last year.
  • According to the latest figures from Q3 2025, Vertex Pharmaceuticals' Assets Average is $24.4 billion, which was up 1540.32% from $23.5 billion recorded in Q2 2025.
  • Vertex Pharmaceuticals' 5-year Assets Average high stood at $24.4 billion for Q3 2025, and its period low was $11.9 billion during Q1 2021.
  • For the 5-year period, Vertex Pharmaceuticals' Assets Average averaged around $18.6 billion, with its median value being $19.7 billion (2023).
  • In the last 5 years, Vertex Pharmaceuticals' Assets Average surged by 3866.68% in 2021 and then crashed by 264.52% in 2025.
  • Over the past 5 years, Vertex Pharmaceuticals' Assets Average (Quarter) stood at $13.0 billion in 2021, then soared by 33.8% to $17.4 billion in 2022, then rose by 27.54% to $22.2 billion in 2023, then rose by 0.71% to $22.4 billion in 2024, then rose by 9.21% to $24.4 billion in 2025.
  • Its last three reported values are $24.4 billion in Q3 2025, $23.5 billion for Q2 2025, and $22.7 billion during Q1 2025.